By Doug Macron

Harvard University's Immune Disease Institute and the Scripps Research Institute pulled in big bucks from the National Institutes of Health last month, each securing grants worth more than $3 million to advance efforts using RNAi as a tool to solve questions related to immunity and learning.

At the same time, microRNA research continues to garner significant NIH support, with three projects related to the small non-coding RNAs receiving more than $1.3 million in combined funding last month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.